Dihexa Side Effects: What Is Reported, the Cancer Question, and What to Report

No row in that table has a percentage, and that is the honest position. There is no trial to take one from.

The medication this page covers:

The price is all-in: medication, physician review, refill management and shipping, with no membership fee. Compounded medications are not FDA approved, and Dihexa is not an approved drug anywhere.

Most side-effect pages are built from a drug label: so many people on the drug, so many on placebo, so many reported nausea. Dihexa has nothing of that kind.

That is why Dihexa was placed in Category 2 of the FDA's 503A bulk substances list in 2023: the stated concern was the complete absence of human exposure data. It was moved out of Category 2 in April 2026 and is scheduled for a Pharmacy Compounding Advisory Committee meeting before the end of February 2027. Leaving Category 2 changed its regulatory position; it did not add any safety data.

Rodent tolerability studies are short and do not answer the questions that matter for people taking a medication for months. Everything below about what people feel comes from prescriber experience, which is real but unpublished and unmeasured.

This is the side-effect question most worth understanding, and it is a question rather than a finding.

The developers of Dihexa proposed that it works by making hepatocyte growth factor (HGF) a stronger activator of its receptor, c-Met. HGF and c-Met are best known from liver regeneration and cancer biology, and c-Met over-activity is a feature of many cancers. If the mechanism is right, Dihexa is stimulating a proliferation pathway.

The absence of evidence either way is the problem. That is why a personal or strong family history of cancer is asked about at intake, why many physicians will not prescribe Dihexa in that situation, and why most prescribers structure it as a defined course with a review rather than indefinite use. More on how this question is handled across peptides is in can peptides cause cancer.

Your physician stays reachable through your account for questions and side effects. If side effects lead to a change, your physician sets your directions after reviewing your intake and how you are doing, and the new directions are printed on the vial. Never change, skip or double a dose on your own.

Allergic reactions to injected peptides are uncommon but real. Stop and contact your physician for any reaction that is severe, spreading, or involves difficulty breathing.

One risk with any multi-dose vial is drawing the wrong amount. Dihexa's typical directions are 0.25 mL, which is 25 units on a U-100 insulin syringe; from the 1 mg/mL vial that is 0.25 mg per dose. Pepti prints the dose in both millilitres and syringe units for the exact vial you receive. If the label does not match what you expected, do not inject; message your care team. If you miss a dose, follow your directions and do not take two doses to make up for one.

Interactions

There is no established interaction list, because the trials that would produce one have not been run. That is why the intake asks for every medication and supplement you take, and why a physician reviews it rather than a form. Some physicians prescribe Dihexa alongside Semax because they act on different systems; no study has tested the combination, so it means two unknowns at once.

Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

A physician cautious about Dihexa's blank safety record will often suggest Semax first. The full comparison is in Dihexa vs Semax.

Dihexa's side-effect profile is not known in the way a drug's is known. The animal work reports it as well tolerated in short studies. Prescribers report mostly minor effects. There is no human trial, no human exposure data, no interaction list and no long-term follow-up. The growth-pathway concern is theoretical and unresolved, and the retraction of the mechanism papers makes it harder, not easier, to reason about.

Any provider describing Dihexa as having "no side effects" or as "safe long term" is claiming something nobody has measured. The fair description is: minor effects reported in practice, and a real gap in knowledge that your physician weighs against your history before prescribing.

Dihexa cannot be bought legitimately without a prescription. Products sold "for research use only" have no accountable pharmacy behind their identity, purity, sterility or concentration, which adds a second unknown to a compound that already has one. The prescription route:

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with ice packs, with sterile syringes and alcohol prep pads, and your directions printed on the vial.
5. Your care team stays reachable for side effects and questions. Refills run every 28 days, one vial per fill.

Pepti is cash-pay and does not bill insurance. The step-by-step page is how to get Dihexa prescribed online.